Trek Financial’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding IDNA
WBG
Trek Financial's IDNA Position: Q3 2026 in Review
Trek Financial increased its iShares Genomics Immunology and Healthcare ETF (IDNA) stake by 1% in Q3 2026, buying an estimated $34.9K and bringing the position to 91,892 shares worth $3.89M. The position accounts for 0.18% of the portfolio, ranked #132.
Trek Financial first reported a position in IDNA in Q2 2026 and has held it in 2 quarters since. 81 funds tracked by Wall St. Rank hold IDNA as of Q3 2026.
- Trek Financial held 91,892 shares of iShares Genomics Immunology and Healthcare ETF worth $3.89M as of Q3 2026.
- Trek Financial bought 952 iShares Genomics Immunology and Healthcare ETF shares in Q3 2026, an estimated $34.9K.
- iShares Genomics Immunology and Healthcare ETF made up 0.18% of Trek Financial's portfolio in Q3 2026, its #132 holding.
- Trek Financial first reported a position in iShares Genomics Immunology and Healthcare ETF in Q2 2026 and has held it in 2 quarters since.
- 81 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q3 2026.
Based on Trek Financial's 13F filing for Q3 2026, filed 29 Oct 2026.